−13.7616USD
−209.42 MUSD
263.00 MUSD
7.72 M
About MORPHOSYS
Sector
Industry
CEO
Jean-Paul Kress
Website
Headquarters
Planegg
Employees (FY)
564
Founded
1992
ISIN
DE000A4BGGU0
FIGI
BBG01MG4VRF4
MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MOR1 is 67.7000 USD — it has increased by 0.59% in the past 24 hours. Watch MORPHOSYS stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange MORPHOSYS stocks are traded under the ticker MOR1.
MOR1 reached its all-time high on May 14, 2024 with the price of 67.7000 USD, and its all-time low was 64.1000 USD and was reached on Apr 30, 2024. View more price dynamics on MOR1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MOR1 stock is 1.04% volatile and has beta coefficient of −1.17. Track MORPHOSYS stock price on the chart and check out the list of the most volatile stocks — is MORPHOSYS there?
Today MORPHOSYS has the market capitalization of 2.80 B, it has increased by 1.16% over the last week.
Yes, you can track MORPHOSYS financials in yearly and quarterly reports right on TradingView.
MOR1 net income for the last quarter is −339.84 M USD, while the quarter before that showed 53.27 M USD of net income which accounts for −737.94% change. Track more MORPHOSYS financial stats to get the full picture.
No, MOR1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 3, 2024, the company has 564.00 employees. See our rating of the largest employees — is MORPHOSYS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MORPHOSYS EBITDA is −471.48 M USD, and current EBITDA margin is −95.29%. See more stats in MORPHOSYS financial statements.
Like other stocks, MOR1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MORPHOSYS stock right from TradingView charts — choose your broker and connect to your account.